long term treatment or in patients with impaired renal function, minimise the likelihood of side effects. They found vancomycin a safe and effective drug to use in children with multiply resistant staphylococcal infections.
Another reason for taking vancomycin off the shelf has been its use in the treatment of antibiotic associated colitis.
Oral vancomycin is not absorbed and has proved to be the most effective ~rug in ridding the colon of toxin producing Clostridium difficile which have been associated with this illness. That use is summarised by ,Fekety and colleagues 5 in the vancomycin review. They found it to be highly effective and remarkably freg~ of serious side effects when given orally.
As a veteran of the staphylococcal era of the 1950's, I must say that it is pleasing to see vancomycin back in action again.
It is to be hoped that we don't see a parallel return of epidemic staphylococcal disease but we can be assured that if that happens, it will be with multiply resistant strains. The cerebrospinal fluid was clear with a protein level of 56 mg%.
A computerized tomographic (CT) scan was negative.
Viral studies were negative.
The child gradually recovered over the next three weeks.
Discussion
A variety of neurologic syndromes may occur following presumed viral infections.
These range from an acute encephalitic picture to acute cerebellar ataxia, transverse myelitis, ascending polyneuropathy, and myositis. Forms of "brain stem encephalitis" also can occur with the constellation of multiple cranial nerve palsies, ataxia, weakness, and cerebellar signs.
C. Miller Fisher, a neurologist at Harvard Medical School, described the syndrome of ophthalmoplegia, ataxia, and areflexia as "an unusual variant of acute idiopathic polyneuritis"
(Guillain-Barr~ syndrome) in the New England Journal of Medicine in 1956.
Since then sporadic cases have continued to be reported. 
